Department Of Biotechnology Dbt
- All
- News
- Videos
-
Applications Invited For Biotechnology Entrance Exam
Graduate Aptitude Test- Biotechnology (GAT-B)/ Biotechnology Eligibility Test (BET) is a national level entrance examination for admission to Biotechnology courses.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
National Institute Of Immunology Gets Trademark For India's First Indigenous Tumor Antigen SPAG9
The SPAG9 antigen developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark, the Department of Biotechnology (DBT) said on Friday.
-
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
-
Indian Scientists Develop Breakthrough Dengue Drug
In a breakthrough move that can help in the fight against dengue, a herbal medicine against it is claimed to have been developed by scientists in India, which accounts for 50 per cent of the global population estimated to be at risk from the disease.
-
Applications Invited For Biotechnology Entrance Exam
Graduate Aptitude Test- Biotechnology (GAT-B)/ Biotechnology Eligibility Test (BET) is a national level entrance examination for admission to Biotechnology courses.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
National Institute Of Immunology Gets Trademark For India's First Indigenous Tumor Antigen SPAG9
The SPAG9 antigen developed by the National Institute of Immunology (NII) has received the ASPAGNIITM trademark, the Department of Biotechnology (DBT) said on Friday.
-
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
-
Indian Scientists Develop Breakthrough Dengue Drug
In a breakthrough move that can help in the fight against dengue, a herbal medicine against it is claimed to have been developed by scientists in India, which accounts for 50 per cent of the global population estimated to be at risk from the disease.
